Arkolith/Insider Trading/TBPH/Form 4

Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRSTheravance Biopharma, Inc. (TBPH) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$218K
Net Open-Market Flow
-$218K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Sell(S)3K$16.39$55K242K
Jun 15, 2026Sell(S)3K$16.38$55K239K
Jun 15, 2026Sell(S)7K$16.39$109K232K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001898490-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML